Latest Trends and Opportunities in Global Virology Market

2018-05-22 10:23:04

According to a new report published by Reports Monitor titled, “Global Virology Market, Growth Opportunities, Innovations and Forecast, 2017-2025,”the virology market was valued at XX million in 2017, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025

During last couple of years many viruses such as Ebola, zika virus affected peoples worldwide which drives the growth of the virology to develop the diagnostic test and medicine to tackle such type of life threatening diseases. Wide range of application developed in virology such as gene therapy, phage therapy and synthetic biology helps to expand its use and boost the growth of the market.    
Constantly growing demand of the medicine for prevention and cure of the viruses diseases are propels the growth of the market. Continuous rising investment in R&D for development of efficient diagnostic test and medication can stimulate the growth of the market. Stringent drug approval process can hampers the growth of the virology market.

To Know More| Request for PDF Brochure @ 

This report provides a detailed analysis of virology market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and swot analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources with bottom-up and top-down approaches.

Segmentation of virology market is majorly focuses on type, application and end user. Based on type the market is segmented into diagnosing test, antiviral chemotherapy, interferons and viral infection controlling methods. While based on application the market is segmented into urinary tract infections, eye infections, cns infections, skin and soft tissue infections, respiratory tract infections, gi tract infections, sexually transmitted diseases and perinatal infections. On the basis of end user the market is segmented into laboratories, diagnostic centres, hospitals, clinics, blood banks and pharmacies.

Global Virology market is majorly analyzed across: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Presence of higher patient base suffering from viruses, increasing healthcare education and government initiative to spread awareness regarding viruses causing diseases are driving the growth of the virology market in Asia-Pacific region. Developed healthcare infrastructure, presence of affordable diagnostic and technological advancement to provide portable diagnostic devices are contributing the growth of the virology market in North America.

Major vendors operating in the global virology market are: GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.      

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Related Press Releases